Mosquitoes exposed to sublethal doses of insecticides may be selected for resistance to insecticide active ingredients (AIs). Mosquitoes are exposed to AIs through agricultural, public/private mosquito control programs, homeowners, and other sources. Hence, mosquito control programs should routinely measure the resistance/susceptibility status of mosquito populations of public health concern. The objectives here were to determine resistance status for six AIs used in adult mosquito control in the United States to assess how resistance/susceptibility differs between AI, mosquito species (states where > 1 species collected), and between years (some populations sampled for 2 yr). Field-collected eggs from 21 mosquito populations of six different species or hybrid species (Aedes albopictus Skuse [Diptera: Culicidae], Aedes aegypti L. [Diptera: Culicidae], Culex nigripalpus Theobald, Culex pipiens L. [Diptera: Culicidae], Culex quinquefasciatus Say [Diptera: Culicidae], Cx. pipiens/quinquefasciatus) were obtained. Centers for Disease Control and Prevention bottle bioassays were used to assess the resistance/susceptibility status for six AIs (bifenthrin, deltamethrin, etofenprox, malathion, permethrin, and phenothrin). World Health Organization guidelines were used to classify mosquitoes as susceptible (98-100% mortality at diagnostic time [DT]), possibly resistant (80-97% mortality at DT), or resistant (<80% mortality at DT). Significant differences were observed in mosquito susceptibility/resistance between species and AIs. In states where both Aedes and Culex were collected, the odds of exhibiting resistance in Culex were 68-69 times higher than Aedes (Texas odds ratio: 69.30; 95% confidence interval: 5.86, 819.44; P = 0.001; North Carolina odds ratio: 67.99; 95% confidence interval: 15.21, 303.94; P < 0.0001). Some level of resistance was detected against all tested AIs in several mosquito populations and some varied between 2015 and 2016.
assess resistance by exposing (male and female) larvae to insecticide solutions (e.g., Liu et al. 2004; Ayesa et al. 2005 , Xu et al. 2005 . Consequently, we evaluated insecticide resistance/susceptibility to two major classes of commonly used insecticides (organophosphates and pyrethroids) in adult females of mosquito species of public health concern. There is currently widespread reliance on pyrethroids in mosquito control, and organophosphates remain in use for public health emergencies (Likos et al. 2016; Smith et al. 2016) .
Mosquito control programs (MCPs) are diverse in the United States and run the gamut from well-organized mosquito control districts, county Environmental Health programs, municipal public works, to private companies providing individual household level control (del Rosario et al. 2014 , Hamer 2016 . All MCPs are tasked with protecting public health from mosquito-borne disease, as well as controlling pests, and many use chemical insecticides to kill adult or larval mosquitoes. In order for a MCP to protect health and provide an effective community service, their mosquito control efforts must be regularly monitored and benchmarked through surveillance (e.g., American Mosquito Control Association 2017). Efficacy testing should be carried out prior to the use of a product and (at least) annually. If control benchmarks are not being met, determining the cause of failure is critical. A potential outcome of chemical control is the evolution of resistance, and this should be one of the causes of failure examined. This can be accomplished by seasonally and spatially monitoring the insecticide resistance/susceptibility status of target mosquito populations. This information informs management decisions about which insecticide products should be used and may vary from year to year, or within a single year, depending on variation in mosquito populations. Other reasons for control failure that should be considered may include equipment calibrations, weather conditions at the time of applications, and vegetation barriers preventing delivery of insecticides to the target population.
In spite of an increasing and comprehensive body of knowledge regarding the genetic basis of insecticide resistance, a sustained nationwide assessment of insecticide resistance for mosquitoes of public health importance in the United States is lacking and mapping of resistance may improve planning of mitigation measures. In 2016, CDC investigators at the Dengue Branch in Puerto Rico conducted resistance tests and mapped resistance to several active ingredients (AIs) (https://www.cdc.gov/zika/vector/testing-puertorico.html). This type of testing and mapping should be considered for other regions where mosquito control is needed. The CDC database called MosquitoNET has been set up, in part, to monitor resistance testing taking place in different states within the United States (CDC 2017 ). In addition, published diagnostic doses (DDs) for U.S. mosquitoes are lacking, especially for Culex species, for many of the AIs used here, hence this study builds baseline knowledge.
The evolution of insecticide resistance in mosquitoes is well known and can occur for commonly used AIs. There is currently widespread usage of pyrethroids and organophosphates in mosquito control, and these types of AIs are evaluated here. Mosquitoes can become resistant to AIs through different mechanisms, e.g., increases in cytochrome P450 monooxygenases that detoxify AIs, mutations in the voltage sensitive sodium channel (kdr genes), increases in metabolism, and other unknown mechanisms (Scott et al. 2015 , Marriel et al. 2016 , Smith et al. 2016 . Some mosquitoes are not considered operationally susceptible to AIs, i.e., show decreased mortality after insecticide treatments but may experience decreases in fitness (e.g., reduced fecundity/fertility, shorter lifespan, etc.) due to AI exposure that may impact population dynamics (Scott et al. 2015) . In some cases, insects can exhibit tolerance (rather than resistance) to sublethal insecticide doses where survival occurs, but resistance is not conferred to offspring (IRAC 2010). As with most biological processes, some individuals within mosquito populations (larvae and/ or adults) may naturally exhibit a greater degree of tolerance to insecticides than others, and this may be difficult to distinguish from genetic resistance (inherited from one generation to the next so is present in some individuals before exposure to an insecticide), especially in areas with continual insecticide applications. Tolerance may be displayed in a generation of insects (such as mosquitoes) that is exposed to some type of stress (e.g., insecticide) and/or in subsequent generations after exposure to a similar type of stressor (Scott 1995) but is not an inherited trait, hence is not long-lasting.
Our objectives in the current study were to: 1) Determine the resistance status of several Culex and Aedes populations of public health importance against AIs commonly used in mosquito control, and 2) assess the extent to which resistance differs between AI, mosquito species, and (in some cases) between years.
Materials and Methods

Mosquitoes
Twenty-five mosquito abatement districts, control programs, universities, and government agencies were contacted within four regions (based on census regions in the United States): https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf. Programs from the following regions mailed eggs that were used in resistance/ susceptibility assays: . Additional programs from these regions mailed us eggs, but we were unable to propagate enough mosquitoes for use in assays: Midwest (Nebraska), South (NC), West (Colorado).
Two susceptible colonies were used as controls in this study: 1) The CDC provided Cx. quinquefasciatus (Sebring strain) and 2) our existing Ae. albopictus colony originating from LA to establish AI doses and diagnostic times (DTs). We tested 21 field mosquito populations of six species from 17 participants (MCPs, universities, government agencies) including Ae. albopictus (N = 8), Ae. aegypti (N = 1), Culex nigripalpus Theobald (N = 1), Cx. pipiens (N = 3), Cx. quinquefasciatus (N = 6), and Cx. pipiens/quinquefasciatus (N = 2) ( Table 1) . Mosquitoes (F 0 -F 5 ) reared from field-collected eggs were processed as described previously (Richards et al. 2017) . For mosquito populations that showed low hatch rate or where we wanted to increase sample size, mosquitoes were blood fed and additional generations propagated (Richards et al. 2017) . The maximum number of generations used was five. For propagation, mosquito eggs were placed into 34 cm by 24 cm plastic pans (Bioquip, Rancho Dominguez, CA) with tap water and placed in incubators with a 14:10 light:dark cycle at 28°C and 85% humidity. Larvae were fed a 2:1 mixture of liver powder and yeast, and pupae were transferred to plastic cups containing tap water, placed into 30.5 cm by 30.5 cm by 30.5 cm square cages (BioQuip), and provided 20% sucrose ad libitum (Richards et al. 2017) . Colonies were separated by mosquito collection location.
to prepare the calibration curve for quantification. Analyses verified that AIs in stock solutions remained undegraded (data not shown).
Bioassays
Adult female mosquitoes were assayed for resistance to six AIs (bifenthrin, deltamethrin, etofenprox, malathion, permethrin, phenothrin) utilizing the CDC bottle bioassay method (CDC 2013) . Stock solutions for bioassays were prepared by mixing each AI with acetone so that the final volume's concentration reflected the typical DD after a DT of 30-60 min ( Table 2) . Stock solutions were refrigerated at 4°C for the duration of the study (CDC 2013) .
DDs used in this study were based on our previous study (Richards et al. 2017 ) and the current study using susceptible longstanding colonies of Ae. albopictus and Cx. quinquefasciatus. We used the same DDs for both Aedes and Culex populations in this study since we were interested in comparative susceptibility of species within these two genera. The DDs used were appropriate for lab colonies of both Ae. albopictus and Cx. quinquefasciatus and were optimized based on preliminary tests of both colonies using a variety of doses.
For deltamethrin, etofenprox, and malathion, two different DDs were used (Table 2 ). In these cases, during the initial determination of DD and DT, susceptible colonies exposed to the same AIs from a previous study carried out in 2015 (Richards et al. 2017) showed slightly different mortality rates than susceptible colonies exposed in the current study carried out in 2016. Consequently, for these three AIs, DDs from the previous study (Richards et al. 2017) were used in addition to doses determined in the current study, for comparison purposes between study years.
For each bioassay (21 mosquito populations × 6 AIs [9 doses]), CDC bottle bioassay procedures were followed (CDC 2013; Richards et al. 2017) . Briefly, the interior of three to four 250-ml glass Wheaton bottles was coated with 1 ml of each AI stock solution or 1 ml of acetone (control) (CDC 2013) . After coating, bottles were uncapped and placed on a bottle roller (Fisher Scientific, Kennesaw, GA) at 20 revolutions/min for 1-2 min until dry. This process left AI residue in the treatment bottles and no AI in the control bottles. All bottles were stored uncapped in a drawer away from light for ≤24 h prior to bioassays. Each mosquito population was assayed for six AIs (nine total doses) on the same day. At least three (population-specific) control bottles were used for each individual mosquito population and were also processed on the same day. Four-to 10-day old labreared adult female mosquitoes from field-collected eggs (Tables 3  and 4 ) were introduced into the bottles, i.e., 4-21 mosquitoes/bottle. Mosquito mortality was recorded at 10 time points (15, 30, 35, 40, 45, 60, 75, 90, 105 , 120 min) following CDC bottle bioassay guidelines (CDC 2013) . Mosquitoes that were knocked down (i.e., not able to stand up or fly) at these time points were classified as dead (CDC 2013) .
Mortality rate was calculated as the number of dead mosquitoes divided by the total mosquitoes multiplied by 100 for each time point, AI and dose, and mosquito collection location. For each species, the mean proportion of dead mosquitoes at the DT was calculated and graphed (Figs. 1-3) (mortality curves are provided as Supplementary Data [Online only]). We used World Health Organization guidelines (as recommended by the CDC) (WHO 2013; CDC 2013) as follows: susceptible (98-100% mortality at DT), possible resistance (80-97% mortality at DT), or resistant (< 80% mortality at DT) (Tables 3 and 4 ). The proportions of tested mosquitoes dead at 30 min (bifenthrin, deltamethrin, etofenprox, permethrin, phenothrin) or 60 min (malathion) were used to determine resistance or susceptibility status.
Data Analyses
Ordinal logistic regression (P < 0.05) (PROC LOGISTIC, SAS Institute, Cary, NC) was used to determine differences, if any, in susceptibility, possible resistance, or resistance between 1) Ae. albopictus and Culex species (pipiens, quinquefasciatus, pipiens/ quinquefasciatus) where species were collected from the same state (analyses conducted for mosquitoes collected from TX and NC) and 2) AIs (for all species and populations). Odds ratios were computed to illustrate the magnitude of differences in resistance observed between species and AIs.
Results
Resistance and Susceptibility Analyses
Mortality data are presented for each species (Figs. 1-3 ). DDs and times are shown in Table 2 . Differences were observed between AIs in levels of resistance and susceptibility (range = 0-100% mortality at DT), and the degree of this variation differed between mosquito 
N indicates the number of mosquitoes tested including all replicates for each AI, location, and mosquito population. Susceptible populations are given in bold.
populations (Tables 3 and 4 ). The number of generations propagated for each population is listed in Tables 3 and 4 (maximum number of generations was five; only three populations used were greater than two generations). All post hoc comparisons (except for the low dose of malathion) show the resistance status of mosquitoes exposed to the low dose of etofenprox was significantly higher than the other AIs in resistance status.
Malathion
Ae. albopictus from FL, CA, three different NC populations and Ae. aegypti from TX were susceptible to both doses (100 and 250 µg/µl) of malathion tested here (Table 3) . Conversely, Ae. albopictus from NC (Greenville) and TX were resistant (range = 0-79% mortality at DT) to the same two malathion doses (Table 3) . One NC population (Bolivia) exhibited possible resistance to both doses of malathion. All tested Culex populations from all locations were resistant (range = 0-64% mortality at DT) to the low dose of malathion (Table 4 ). For the high dose of malathion, 75% (N = 9 out of 12) or 25% (N = 3 out of 12) of Culex populations were respectively resistant (range = 0-78% mortality at DT) or possibly resistant (range = 82-94% mortality at DT) (Table 4 ).
Etofenprox
Most Aedes populations were resistant to the low dose of etofenprox (6 µg/µl) used here; however, Ae. albopictus from CA exhibited possible resistance (range = 0-100% mortality at DT) to this dose (Table 3) . Ae. aegypti from TX were resistant to the high dose of etofenprox (15 µg/µl) used here and Ae. albopictus from FL exhibited possible resistance (Table 3) . Six populations of Ae. albopictus (NC, TX, CA) were susceptible to the high dose of etofenprox (Table 3 ). All Culex spp. (range = 0-78% mortality at DT) populations were resistant to etofenprox at the two doses (Table 4 ).
Bifenthrin
Six populations of Ae. albopictus (FL, NC, TX) were susceptible to bifenthrin (12.6 µg/µl) and two populations (Ae. aegypti from TX and Ae. albopictus from CA) were resistant (Table 3) . Possible resistance was shown in one NC (Bolivia) Ae. albopictus population. Possible resistance was detected in two Culex (range = 81-89% mortality at DT) populations, and resistance was shown in the remaining 10 Culex populations (range = 0-72% mortality at DT) ( Table 4 ).
Permethrin
Seven Aedes spp. populations were susceptible (100%) to permethrin (15 µg/µl) and one population (Ae. aegypti from TX) was resistant (Table 3) . Possible resistance was shown in one NC (Bolivia) Ae. albopictus population. All Culex spp. were resistant to permethrin (range = 0-66% mortality at DT) (Table 4 ).
Phenothrin
All tested Ae. albopictus spp. populations were susceptible (100%) to phenothrin (23 µg/µl) and one population (Ae. aegypti from TX) was resistant (Table 3 ). Ten Culex populations were resistant (range = 0-72% mortality at DT) to permethrin, one population (Cx. pipiens from MN) was possibly resistant, and one population (Cx. pipiens from PA) was susceptible (Table 4) . 
Deltamethrin
For the low dose (5 µg/µl) of deltamethrin used here, six Ae. albopictus populations were susceptible and the remaining three Aedes spp. populations exhibited possible resistance (range = 85-94% mortality at DT) (Table 3) . At the high deltamethrin dose (10 µg/µl) used here, seven Ae. albopictus populations were susceptible and two Aedes spp. (Ae. albopictus from FL and Ae. aegypti from TX) were possibly resistant (range = 93-96% mortality at DT) (Table 3 ). Four Culex populations exhibited possible resistance (range = 81-95% mortality at DT) to the low deltamethrin dose, while the remaining eight populations were resistant (Table 4 ). For the high dose of deltamethrin, two Culex populations were susceptible (Cx. pipiens from MN and PA) and three populations showed possible resistance (range = 87-97% mortality at DT) ( Table 4 ). The remaining seven Culex populations were resistant to the high dose of deltamethrin (Table 4 ). Significant differences were observed in mosquitoes (categorized as susceptible, possibly resistant, or resistant) between species from TX (Ae. albopictus, Cx. quinquefasciatus) (df = 1, χ 2 = 11.31, P = 0.001) and NC (Ae. albopictus, Cx. pipiens/quinquefasciatus) (df = 1, χ 2 = 30.50, P < 0.0001) with Culex showing a higher degree of resistance than Aedes. The odds of Culex spp. mosquitoes being resistant were 69 (TX) and 68 (NC) times higher than the Ae. albopictus tested here.
Compared to bifenthrin, the odds of mosquitoes being resistant to the low dose of etofenprox were seven times greater (P = 0.022). Similarly, compared to the low and high doses of deltamethrin, the odds of mosquitoes being resistant to the low dose of etofenprox were 10 and 14 times higher (P = 0.006 and P = 0.002). Compared to the high dose of etofenprox, the odds of mosquitoes being resistant to the low dose of the same AI were six times greater (P = 0.028). Compared to phenothrin, the odds of resistance to the low dose of etofenprox was 11 times greater (P = 0.005). The same trend was true for the high dose of malathion (P = 0.013) and permethrin (P = 0.006) in that mosquitoes showed odds eight times higher of exhibiting resistance to the low dose of etofenprox.
Comparison Between 2015 and 2016
Two Ae. albopictus (FL and CA) and three Culex (Cx. pipiens from MN and UT; Cx. pipiens/quinquefasciatus from NC) populations were collected from the same counties in our study conducted in the 2015 (Richards et al. 2017 ) and the current study (conducted in 2016). For FL Ae. albopictus, the following differences were observed between years for low-dose malathion (2015: resistant, 2016: susceptible), bifenthrin (2015: possible resistance, 2016: susceptible), and deltamethrin (2015: susceptible, 2016: possible resistance). For the same Ae. albopictus in FL, no change was observed in susceptibility/resistance status for low-dose etofenprox (resistant), permethrin (susceptible), or phenothrin (susceptible). For the CA Ae. albopictus, yearly differences were observed for low-dose malathion (2015: resistant, 2016: susceptible), low-dose etofenprox (2015: resistant, 2016: possible resistance), bifenthrin (2015: possible resistance, 2016: resistant), and permethrin (2015: possible resistance, 2016: susceptible). In an Ae. albopictus population collected from the same area, no difference was observed between 2015 and 2016 for phenothrin or high-dose deltamethrin as mosquitoes in both years were susceptible to these AIs.
Cx. pipiens from MN only exhibited changes from year to year in response to permethrin (2015: possible resistance, 2016: resistance), while all other AIs showed no change between years (lowdose malathion: resistant, low-dose etofenprox: resistant, bifenthrin: possible resistance, phenothrin: possible resistance, high-dose deltamethrin: susceptible). For Cx. pipiens/quinquefasciatus from NC (Curry Court in Greenville), one change was noted in high-dose deltamethrin between 2015 (possible resistance) and 2016 (resistant). For this NC population, no changes were observed between the other AIs as all exhibited resistance for both 2015 and 2016. For Cx. pipiens from UT, their response to high-dose deltamethrin changed from 2015 (susceptible) to 2016 (possible resistance); however, mosquitoes exposed to all other AIs showed no yearly change as all remained resistant.
Discussion
We tested the hypothesis that mosquito populations have variable resistance to one organophosphate and several pyrethroid insecticides, depending on species and year. We found support for our hypothesis, as some tested populations have resistance to several pyrethroids. We also found differences between years, and that one AI, the low dose of etofenprox used here, was consistently less effective than the other tested AIs. This is practical information for mosquito control operators and may serve as a starting point for insecticide resistance/susceptibility analyses in their own regions.
The CDC recommends testing AIs that are currently being used or have recently been used, as well as others that are available for use (in case an alternative is needed) (CDC 2016b) . It should be noted that resistance/susceptibility profiles found for technical grade AIs are not directly related to the efficacy of formulated products that contain additional ingredients (e.g., synergists that inhibit detoxification enzymes) that may improve efficacy. Thus, documented resistance in our assays does not mean a product will fail in a field application. Studies are underway to assess the relationships between selected AIs and associated formulated products via bottle bioassay. Although bottle bioassays are not a direct measure of field applications/conditions, the assays do evaluate resistance to AIs of the mosquito populations. Thus, the results should be interpreted with careful consideration for operational, genetic, and other relevant factors. We have used WHO classification for susceptibility/ resistance here (as recommended by CDC guidelines; CDC 2013) so that some populations could be compared between years (WHO classifications used in previous study; Richards et al. 2017) . Future studies will use CDC classifications of susceptibility/resistance that provide different measures.
We found differences in levels of resistance in collections sampled from the same place in consecutive years. We will expand these studies to include repeated testing of the same mosquito populations over the mosquito season in order to evaluate temporal changes in resistance/susceptibility in certain populations. Within season changes in resistance are known from agricultural settings, so the time of collection during the season may be important. The timing of population sampling may be even more important if chemicalbased control practices are employed early in the season. We did not assess differences in control measures between years as this would be difficult to measure since there could be multiple sources of control, i.e., public/private pest control, agriculture, homeowner, and other unknown sources.
We expect resistance/susceptibility trends to change over time and with insecticide pressure. Furthermore, cross resistance (i.e., mosquitoes that become resistant to one pyrethroid may also become resistant to different pyrethroids in that class) may be an issue (Nauen 2007) , especially where we observed widespread resistance in Culex species tested here. Cross resistance may occur when insecticides have similar (or the same) modes of action (Scott 1995) .
Here, we have only tested two Aedes species (Ae. albopictus and Ae. aegypti) and four Culex species or hybrid species (Cx. nigripalpus, Cx. pipiens, Cx. pipiens/quinquefasciatus, Cx. quinquefasciatus) . Three of the Ae. albopictus populations tested here were propagated for more than two generations (up to five generations) in the laboratory. Further testing of additional species and populations is warranted, depending on the regional needs of MCPs, as species diversity in resistance status may be important. Routine testing of multiple populations throughout mosquito control districts are certainly warranted due to (species, population, and seasonal) variability expected to occur.
In TX and NC where both Culex and Aedes species were sampled, we found that Aedes spp. showed greater susceptibility to AIs compared to the Culex spp. These results corroborate the findings of Richards et al. (2017) that conducted a similar study for mosquitoes collected in 2015. Others have also shown spatiotemporal differences in susceptibility of Ae. aegypti to deltamethrin (10 µg/ bottle; tested here), bendiocarb (12.5 µg/bottle; not tested here), and chorpyrifos (50 µg/bottle; not tested here) (Deming et al. 2016) . The same study showed a relationship between deltamethrin resistance and knock down resistance alleles (Ile1016 and Cys1534). Another study (using insecticide-treated papers following guidelines of a WHO tube assay for a 60-min exposure time, not the CDC bottle bioassay) assessed resistance/susceptibility of adult Ae. albopictus (New Jersey, PA, FL) to deltamethrin, phenothrin, and malathion (among others) (Marcombe et al. 2014) . The same study showed susceptibility to deltamethrin and phenothrin; however, some mosquito populations from FL exhibited resistance to malathion. Since most published studies on Culex have exposed larvae (not adults) to insecticide solutions (e.g., Liu et al. 2004; Ayesa et al. 2005 , Xu et al. 2005 , results from those studies are not comparable to our study where we exposed adults to insecticides in bottle bioassays. Another study using the CDC bottle bioassay showed resistance in one population of Cx. pipiens from CA exposed to permethrin (60min DT; 30 µg permethrin/bottle), resmethrin (d-phenothrin) (45min DT; 10 µg phenothrin/bottle), and resistance to those exposed to malathion (DT not reported; 100 µg malathion/bottle) (McAbee et al. 2003) . When considered with our findings, it is clear that variation in susceptibility varies among different mosquito populations and we reiterate that resistance/susceptibility testing (with technical grade and/or formulated products) should be carried out regularly.
There may be different insecticide selection enacted on dayactive mosquitoes, such as Ae. albopictus and Ae. aegypti, compared to Culex species that are active at dusk and dawn (Richards et al. 2017) . Currently, the primary method for controlling Ae. albopictus and Ae. aegypti is reduction of oviposition sites (Smith et al. 2016) and barrier sprays that persist on vegetation where mosquitoes rest. Other methods, such as the sterile insect technique (the release of male genetically modified mosquitoes carrying a dominant lethal gene) and Wolbachia-infected mosquitoes are being used in some regions (e.g., Australia, South America, United States-CA, KY, NY) for controlling these day-active mosquitoes; however, insecticide are generally the preferred method for control in disease outbreak situations (Dobson et al. 2016 , Smith et al. 2016 , Schmidt et al. 2017 ).
In the current study, AI doses and DTs were based on susceptible Aedes and Culex laboratory colonies. MCPs interested in conducting insecticide resistance/susceptibility testing can use our (or the CDC's) AI-specific doses as a starting point for establishing baseline doses and DTs unique to their target mosquito population. However, as we have shown here, even laboratory colonies maintained in the same laboratory can show differences in susceptibility from year to year (as evidenced by some DD differences used in 2015 compared to 2016 here). It is important to monitor seasonal trends in resistance/ susceptibility for field mosquito populations of interest to local programs. Control programs should also consider evaluating resistance/ susceptibility to formulated insecticide products as these products are expected to have additional ingredients that may impact mortality rate (compared to technical grade AIs used here). Data from bottle bioassays using technical grade AIs are not necessarily directly correlated to field doses of formulated products, and these results should not be extrapolated to inform state-wide decisions on mosquito control applications. Furthermore, different products may be designed to persist on foliage for weeks (such as barrier spray products), while other products provide more short-term control (ultra-low volume [ULV] products). When designing the appropriate insecticide resistance/susceptibility monitoring plan, all of these components should be considered to assist in development of mosquito control policies.
Another factor to consider is the impact of insecticide resistance pressure from sources other than private or public MCPs. It is known that agricultural applications of insecticides can impact mosquito populations, even though mosquitoes are not the target of this application (e.g., Kibuthu et al. 2016; Luc et al. 2016) . Mosquito larvae and adults may be exposed to insecticides used in agriculture. In addition, homeowners may apply insecticide products (for mosquitoes and other pests) to their properties, and this can influence insecticide resistance/susceptibility. For example, the Cx. pipiens/ quinquefasciatus collected from Greenville, NC (Curry Court) was sampled from a retention pond in an area known to receive little to no insecticide treatment. However, Greenville, NC is located in a region of substantial agricultural production. Hence, runoff from nearby impervious surfaces (e.g., parking lots) may contain insecticide (or other) residue that could have contributed to this mosquito population's high degree of resistance to most of the AIs. Future studies are planned to evaluate the impact of agricultural runoff (containing AIs commonly used in adulticides) in relation to larval resistance/susceptibility and subsequent adult resistance. MCPs may also consider communicating with agricultural operations in order to determine the type and frequency of AIs being used. The runoff issue would not apply to container-inhabiting Aedes mosquitoes, hence this may be another reason contributing to differences in susceptibility/resistance we observed between Culex and Aedes mosquitoes. Others have shown high mortality rates in Ae. aegypti exposed to deltamethrin (Marriel et al. 2016) . It is possible that droplets drifting from ULV or barrier insecticide sprays may enter containers with Ae. aegypti or Ae. albopictus larvae, hence causing mortality. This should be investigated further.
Insecticide resistance in mosquitoes is a growing issue of global concern (Smith et al. 2016). As pathogens such as DENV, WNV, ZIKV, malaria protozoans, and others continue to impact public health, MCPs should be vigilant to ensure the most efficacious control methods are being used. Resistance should be regularly monitored by more MCPs, and the types of AIs and dosages of products should be adjusted, based on these findings. In any case, targeted (to certain species and populations) surveillance-based mosquito control (rather than widespread calendar-based or complaint-based control) should be carried out to minimize the amount of insecticides applied. MCPs may consider rotating classes of products with different modes of action in order to minimize or delay the development of resistance (e.g., Nauen 2007) and/or using a product that contains more than one AI. Mosquito populations that are resistant to an insecticide with one mode of action may revert back to susceptible status over time after that insecticide is no longer used; however, the speed of this reversion depends on the degree of fitness costs incurred by the mosquito and other factors (IRMC 2010).
Insecticide resistance is a complex issue; however, the aforementioned practices have the potential to reduce the incidence of resistance in mosquito populations. More research is needed on fitness costs incurred by mosquitoes exposed to insecticides, but not killed, as this can inform risk assessments and models of epidemic and enzootic cycles. In addition to surveillance-based targeted control, it is increasingly important to develop new AIs with innovative modes of action and formulated products that target mosquitoes in different ways. As development of new AIs and products is expensive, maintaining the efficacy of current products is important and economically beneficial.
